Quantcast
Last updated on April 17, 2014 at 1:21 EDT

Latest Islet cell transplantation Stories

2012-06-04 02:26:34

NEW YORK, June 4, 2012 /PRNewswire/ -- Islet Sciences, Inc., (OTCBB: ISLT) a biotechnology company engaged in the research, development and commercialization of patented technologies in the field of transplantation therapy for patients with diabetes, today announced that it will present at the upcoming 12th Joint Annual Meeting of the American Society of Transplant Surgeons and the American Transplantation (2012 American Transplant Congress). The event will be held from June 2(nd) - June...

2012-05-10 10:25:24

New combination therapy approach may have possible application in other autoimmune diseases DUARTE, Calif., May 10, 2012 /PRNewswire-USNewswire/ -- City of Hope researchers developed a combination therapy to treat late-stage type 1 diabetes that appears to offer a potential lifetime cure for the disease without toxic side effects. The laboratory study is published in the May 9 edition of Science Translational Medicine. "Our findings indicate that it is possible to cure late-stage type...

2012-03-27 02:27:04

NEW YORK, March 27, 2012 /PRNewswire/ -- Islet Sciences, Inc., (OTC.BB: ISLT) a biotechnology company engaged in the research, development and commercialization of patented technologies in the field of transplantation therapy for patients with diabetes, today named six inaugural members to its Scientific Advisory Board: Dr. Paul Johnson, Dr. Jonathan Lakey, Dr. Steven Paraskevas, Dr. Miguel Riella, Dr. Christian Mende and Dr. Jerry Nadler. "Clearly this esteemed group of Doctors will be...

2012-03-20 10:24:52

MIAMI, March 20, 2012 /PRNewswire-USNewswire/ -- New findings from a transplant study led by scientists from the Diabetes Research Institute (DRI) at the University of Miami Miller School of Medicine and a DRI Federation center at Xiamen University in China showed that mesenchymal stem cells may replace a powerful anti-rejection drug in transplant recipients. The results of this pioneering study involving kidney transplant patients is published in the March 21 issue of the Journal...

2012-03-16 10:21:18

HOLLYWOOD, Fla., March 16, 2012 /PRNewswire-USNewswire/ -- Hope, health and harmony will combine at the second Walk with Walgreens Family Fun Day and Health Fair, where singer/songwriter Crystal Bowersox will give an acoustic performance, presented by LifeScan, Inc. makers of the OneTouch® Brand of blood glucose monitoring systems for people with diabetes. To be held on Saturday, March 24 at Central Broward Regional Park, the event will benefit the Diabetes Research Institute -...

2012-03-07 13:00:00

First-of-its-kind study where donor, recipient are not related or immunologically matched CHICAGO, March 7, 2012 /PRNewswire-USNewswire/ -- New ongoing research published today in the journal Science Translational Medicine suggests organ transplant recipients may not require anti-rejection medication in the future thanks to the power of stem cells, which may prove to be able to be manipulated in mismatched kidney donor and recipient pairs to allow for successful transplantation without...

2012-03-01 11:48:00

MIAMI, March 1, 2012 /PRNewswire-USNewswire/ -- Scientists at the Diabetes Research Institute have developed a revolutionary technique to provide critical oxygen for maintaining the survival of insulin-producing cells. This is the first time that scientists have been able to successfully deliver oxygen locally to beta cells using a biomaterial. The results of the study, which represents a major step toward the goal of developing an alternative site to house insulin-producing cells, were just...

2012-02-29 10:30:00

NEW YORK, Feb. 29, 2012 /PRNewswire/ -- Islet Sciences, Inc. (OTC.BB: ONCED), a biotechnology company engaged in the research, development and commercialization of patented technologies in the field of transplantation therapy for patients with diabetes, today announced that the company entered into a Share Exchange Agreement to acquire DiaKine Therapeutics, Inc. ("DTI"), a biopharmaceutical company developing new, proprietary drugs for unmet medical needs in diabetes and...

2012-02-17 11:02:20

Classes spur patients to get evaluated for a kidney transplant Highlights     Kidney transplantation is the preferred treatment for kidney failure patients, but blacks are less likely to receive kidney transplants than whites.     Kidney failure patients–particularly blacks and those living in poor neighborhoods–who take part in an education program are more likely to get evaluated for a kidney transplant.     Requiring a formal...

2012-02-01 23:41:32

Pilot study shows 60 percent of children who received liver tissue from a parent can safely discontinue immunosuppression; larger study planned Physicians at three transplant centers have found in a pilot study that a majority of children who receive liver tissue from a parent can eventually stop using immunosuppression (anti-rejection) medications safely. These drugs, which tamp down natural immune function, have been linked to a bevy of complications, including cancer, diabetes,...